Table 1.
Maternal and neonatal characteristics and data from the main study NeoSupra Trial*
| Characteristics | SpO2 study N=49 |
NeoSupra Trial* FM group N=597 |
| Median maternal age, years (IQR) | 24 (21–28) | 23 (20–28) |
| Amniotic fluid—meconium stained, foul smelling or both, n (%) | 36 (73) | 370 (62) |
| Caesarean section, n (%) | 41 (84) | 301 (50) |
| Median birth weight, g (IQR) | 3100 (2800–3300) | 3100 (2800–3400) |
| Male sex, n (%) | 32 (65) | 349 (59) |
| Median Apgar score, (IQR) | ||
| 1 min | 3 (2–4) | 3 (2–4) |
| 5 min | 6 (4–6) | 5 (4–6) |
| 10 min | 7 (6–8) | 7 (6–8) |
*Pejovic et al.17
FM, face mask; SpO2, peripheral capillary oxygen saturation.